Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPOSER: Crovalimab in Healthy Volunteers and Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT03157635Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2016
- Primary completion
- Aug 2026
- Countries
- 7
01
Overview
A Phase 2 trial of crovalimab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Roche. Started Nov 2016; status: completed.
02
Drugs
crovalimab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on NCT03157635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03157635.